Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

JOHNSON & JOHNSON

JNJ · NYSE · CIK 0000200406 · Healthcare · Drug Manufacturers—General

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

21 Form 4 transaction lines observed in the same window
11 sales · 10 option, withholding, award, gift or other lines

Last qualifying purchase2025-11-26 · MORIKIS JOHN G · $257.7K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Duato JoaquinCEO and Chairman of the Board
▼○▼
Schmid TimothyEVP, WW Chair, MedTech
○▼
Wengel Kathryn EEVP, Chief TO and Risk Officer
○▼
REED JOHN CEVP, Innovative Medicine, R&D
○○
Taubert Jennifer LEVP, WWC. Innovative Medicine
○▼
Forminard ElizabethEVP, Chief Legal Officer
○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-11-26 · MORIKIS JOHN G.

Recent Form 4 activity

1Purchases
28Sales
113Other Form 4 lines
27SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING11 sale line(s) · context only
OTHER10 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
22,070,973
Previous report
21,188,522
Avg daily volume
6,751,004
Days to cover
3.3

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-11-26MORIKIS JOHN GPurchase (P)Common Stock1,250USD 206.15USD 257,688SEC filing ↗
2024-12-12WEINBERGER MARK APurchase (P)Common Stock1,000USD 147.22USD 147,220SEC filing ↗
2024-04-30Woods Eugene A.Purchase (P)Common Stock100USD 145.53USD 14,553SEC filing ↗
2020-03-13PEREZ WILLIAM DPurchase (P)Common Stock500USD 127.69USD 63,845SEC filing ↗

Form 4 evidence

142 transaction lines in the latest 365-day window; 811 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-02Schmid TimothySale (S)Common Stock33,597USD 274.74USD 9,230,440SEC filing ↗
2026-09-02Schmid TimothyOption exercise / conversion (M)Common Stock33,597USD 144.99USD 4,871,389SEC filing ↗
2026-08-17Taubert Jennifer LSale (S)Common Stock15,000USD 263.36USD 3,950,400SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-02Schmid TimothySale (S)Common Stock33,597USD 274.74USD 9,230,440SEC filing ↗
2026-09-02Schmid TimothyOption exercise / conversion (M)Common Stock33,597USD 144.99USD 4,871,389SEC filing ↗
2026-08-17Taubert Jennifer LSale (S)Common Stock15,000USD 263.36USD 3,950,400SEC filing ↗
2026-08-17Taubert Jennifer LOption exercise / conversion (M)Common Stock15,000USD 115.67USD 1,735,050SEC filing ↗
2026-08-13Duato JoaquinSale (S)Common Stock123,291USD 261.17USD 32,199,927SEC filing ↗
2026-08-13Duato JoaquinOption exercise / conversion (M)Common Stock123,291USD 115.67USD 14,261,070SEC filing ↗
2026-08-06Forminard ElizabethSale (S)Common Stock15,918USD 257.00USD 4,090,993SEC filing ↗
2026-08-06Forminard ElizabethOption exercise / conversion (M)Common Stock9,344USD 131.94USD 1,232,847SEC filing ↗
2026-08-05Duato JoaquinSale (S)Common Stock48,480USD 258.15USD 12,515,184SEC filing ↗
2026-07-20Broadhurst VanessaSale (S)Common Stock23,054USD 251.27USD 5,792,779SEC filing ↗
2026-07-20Broadhurst VanessaOption exercise / conversion (M)Common Stock23,054USD 130.77USD 3,014,701SEC filing ↗
2026-06-11Wengel Kathryn ESale (S)Common Stock10,000USD 241.15USD 2,411,500SEC filing ↗
2026-06-11Wengel Kathryn EOption exercise / conversion (M)Common Stock10,000USD 115.67USD 1,156,700SEC filing ↗
2026-05-01REED JOHN COption exercise / conversion (M)Common Stock25,255USD 0.00USD 0SEC filing ↗
2026-05-01REED JOHN CTax withholding (F)Common Stock11,002USD 229.85USD 2,528,810SEC filing ↗
2026-02-27Decker Robert JSale (S)Common Stock4,075USD 247.87USD 1,010,070SEC filing ↗
2026-02-27Decker Robert JOption exercise / conversion (M)Common Stock4,075USD 115.67USD 471,355SEC filing ↗
2026-02-20Schmid TimothySale (S)Common Stock1,322USD 245.66USD 324,763SEC filing ↗
2026-02-18Schmid TimothySale (S)Common Stock22,623USD 244.33USD 5,527,506SEC filing ↗
2026-02-18Schmid TimothyOption exercise / conversion (M)Common Stock22,623USD 121.17USD 2,741,335SEC filing ↗
2026-02-17Wolk Joseph JSale (S)Common Stock89,654USD 242.80USD 21,767,827SEC filing ↗
2026-02-17Wolk Joseph JOption exercise / conversion (M)Common Stock64,693USD 126.65USD 8,193,223SEC filing ↗
2026-02-17Swanson James D.Sale (S)Common Stock20,521USD 242.70USD 4,980,447SEC filing ↗
2026-02-17Swanson James D.Option exercise / conversion (M)Common Stock20,521USD 164.62USD 3,378,167SEC filing ↗
2026-02-17REED JOHN CSale (S)Common Stock53,931USD 243.00USD 13,105,233SEC filing ↗
2026-02-17REED JOHN COption exercise / conversion (M)Common Stock51,648USD 156.89USD 8,103,281SEC filing ↗
2026-02-17Broadhurst VanessaSale (S)Common Stock6,197USD 243.39USD 1,508,288SEC filing ↗
2026-02-15Wolk Joseph JOption exercise / conversion (M)Common Stock3,849USD 0.00USD 0SEC filing ↗
2026-02-15Wolk Joseph JTax withholding (F)Common Stock1,675USD 243.45USD 407,779SEC filing ↗
2026-02-15Wengel Kathryn EOption exercise / conversion (M)Common Stock1,241USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerJNJ
CIK0000200406
SectorHealthcare
IndustryDrug Manufacturers—General Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNYSE

Data coverage

Local Form 4 history811 transaction lines from 2020-01-30 to 2026-09-02
4 P purchase lines · 254 S sale lines · 553 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.